Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Choksi AsiaBOM:530427 +1.56%52 FCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates BOM:530427 with a GF Score™ of 52/100. The stock has 8 warning signs investors should review. Among 814 Medical Devices & Instruments companies, Choksi Asia ranks better than 50.12% on this metric.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Choksi Asia's Free Cash Flow for the
three
months ended in Mar. 2026 was ₹0.0 Mil. Choksi Asia's Revenue for the
three
months ended in Mar. 2026 was ₹118.6 Mil. Therefore, Choksi Asia's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.
The historical rank and industry rank for Choksi Asia's FCF Margin % or its related term are showing as below:
BOM:530427'
s FCF Margin % Range Over the Past 10 Years
Min: -350.95 Med: -5.35 Max: 23.79
Current: -0.7
During the past 13 years, the highest FCF Margin % of Choksi Asia was 23.79%. The lowest was -350.95%. And the median was -5.35%.
BOM:530427's FCF Margin % is ranked better than 50.12% of 814
companies
in the Medical Devices & Instruments industry
Industry Median: -0.705
vs BOM:530427: -0.70
The historical data trend for Choksi Asia's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:530427 vs ABT, SYK, MDT: FCF Margin % Comparison
For the Medical Devices subindustry, Choksi Asia's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Choksi Asia FCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Choksi Asia's FCF Margin % distribution charts can be found below:
* The bar in red indicates where Choksi Asia's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Choksi Asia (BOM:530427) has a FCF Margin % of 0.00% as of Mar. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Choksi Asia and its competitors. According to the industry distribution chart, Choksi Asia ranks #406 out of 814 companies in the Medical Devices & Instruments industry, placing it in the top 49.9%.
Is Choksi Asia's FCF Margin % too high?
Choksi Asia's current FCF Margin % is 0.00%. Based on the distribution chart, Choksi Asia ranks #406 out of 814 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Choksi Asia has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Choksi Asia's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Choksi Asia ranks #406 out of 814 companies for FCF Margin %. This puts Choksi Asia in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Choksi Asia and its competitors. Choksi Asia's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Choksi Asia stock overvalued right now?
Choksi Asia (BOM:530427) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Choksi Asia's overall GF Score™ is 52/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Choksi Asia (BOM:530427), the current FCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Choksi Asia Ltd formerly Choksi Imaging Ltd is an India-based company engaged in the manufacturing of photosensitized materials, medical X-rays, and other healthcare products. The company sells and derives revenue from products like X-ray films, ultrasound, computed radiography systems, specialty X-ray films, etc. In addition, the company also offers maintenance services for X-ray processors, equipment, and computer radiography systems. The firm provides various photographic, and ultrasonic sound services in association with Protec, Medtron, and others.
52GF Score
Get the complete analysis for BOM:530427
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:530427 has been successfully added to your 
